Deals
Valeant trumps Endo with increased bid for Salix Pharma
Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash, topping Endo International Plc's bid of $10.93 billion in cash and stock for the bowel drug maker.
NZ's Fonterra buys stake in China's Beingmate for $553 million
New Zealand's Fonterra Co-operative Group Ltd (FCG.NZ) said it paid $553 million for a near 20 percent stake in China's Beingmate Baby and Child Food Co. Ltd (002570.SZ), as it looks to boost its presence in the country's branded dairy industry.
KKR, Varde, Deutsche seek to securitize $5.3 billion of GE Capital debt
A group comprising KKR & Co, Varde Partners and Deutsche Bank are looking to securitize about A$7 billion ($5.33 billion) of debt they acquired from a unit of GE, three sources with knowledge of the matter said.
Bain-backed MYOB to file for $2.3 billion Australia IPO by end-March: sources
Bankers running the expected A$3 billion ($2.29 billion) initial public offering of Australian software firm MYOB Ltd, owned by Bain Capital, plan to file a prospectus for the sale by end-March, two people familiar with the matter told Reuters.